SUNNYVALE, Calif.--(BUSINESS WIRE)--Labcyte Inc., a company revolutionizing life science research with its patented acoustic liquid handling technology, congratulates Dr. Jonathan Wingfield, Associate Principal Scientist, Discovery Sciences, Screening Sciences and Sample Management at AstraZeneca for receiving the Innovation Award and a $10,000 prize at SLAS2015, the annual conference and exhibition of the Society for Laboratory Automation and Screening (SLAS), held Feb. 7-11 in Washington D.C. His presentation, now available for viewing on the SLAS website (http://www.slas.org/slas2015-webinar/), is titled “Novel Acoustic Loading of a Mass Spectrometer — Towards Next Generation High Throughput MS Screening.”
Dr. Wingfield presented preliminary results for the application of Labcyte’s acoustic liquid handling to directly load a mass spectrometer. The SLAS Innovation Award is presented to the “podium presentation at the SLAS Annual Conference that proves to be exceedingly innovative and contributes to the exploration of technologies in the laboratory, exceeds a benchmark or milestone in screening or the lead discovery process, or demonstrates an advanced and integrated use of mature technologies.”
The goal of this work, performed in collaboration between AstraZeneca and Labcyte, is to expand the utility of mass spectrometry for high-throughput, low-cost, label-free analysis. This capability would expand the use of mass spectrometry-based analysis throughout the entire drug discovery and development process. Dr. Wingfield presented data from a prototype instrument developed by Labcyte, capable of injecting at a rate of three samples per second, or nearly 30 times faster than the commercially available techniques used today.
This data shows promise for the acoustic liquid handling technique in the analysis of small molecules, simple proteins and more complex large proteins. “Direct infusion mass spectrometry offers a significant step change in throughput,” said Dr. Wingfield. “The ability to load 10,000 samples per hour is now a realistic objective that would enable HTS to exploit the full potential of mass spectrometry. Acoustic technology means contactless sample delivery, and therefore low carryover, ultra-low sampling volumes and very high loading rates.”
The next step in the collaboration will focus on further characterizing the breadth of capabilities for this technology with the ultimate goal of launching a commercial product available to all researchers. “The SLAS Innovation Award is great recognition of the outstanding work that has been done by Dr. Wingfield and his team and serves as a testament to the accomplishments that can be achieved when innovative companies and thought leaders work together,” said Mark Fischer-Colbrie, Labcyte President and CEO. “The award also indicates the tremendous value a commercial product would bring to organizations looking to improve assays, sample measurement and experimental results.”
About Labcyte Inc.
Labcyte, a global biotechnology tools company headquartered in Sunnyvale, California, is revolutionizing liquid handling. Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, as well as by biotechnology companies, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, personalized medicine, and imaging mass spectrometry. Labcyte has 55 U.S. patents and others internationally. For more information, visit www.labcyte.com.